Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;106:1716-1721
Published online before print September 3, 2002, doi: 10.1161/01.CIR.0000030188.50326.8D
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
106/13/1716    most recent
01.CIR.0000030188.50326.8Dv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hockings, P. D.
Right arrow Articles by Benson, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hockings, P. D.
Right arrow Articles by Benson, G. M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Medline Plus Health Information
*MRI Scans
Related Collections
Right arrow Animal models of human disease
Right arrow Pathophysiology
Right arrow Genetically altered mice
Right arrow Imaging

(Circulation. 2002;106:1716.)
© 2002 American Heart Association, Inc.


Basic Science Reports

Repeated Three-Dimensional Magnetic Resonance Imaging of Atherosclerosis Development in Innominate Arteries of Low-Density Lipoprotein Receptor-Knockout Mice

Paul D. Hockings, PhD; Toby Roberts, BSc Hons; Graham J. Galloway, PhD; David G. Reid, PhD; Dorothy A. Harris; Martin Vidgeon-Hart, AIBMS*; Pieter H.E. Groot, PhD; Keith E. Suckling, PhD; G. Martin Benson, PhD

From the Imaging Group (P.D.H., T.R., D.G.R., M.V.-H.), GlaxoSmithKline, The Frythe, Welwyn, UK; the Centre for Magnetic Resonance (G.J.G.), University of Queensland, St Lucia, Australia; and the Department of Atherosclerosis (D.A.H., P.H.E.G., K.E.S., G.M.B.), GlaxoSmithKline Medicines Research Centre, Stevenage, UK.

Correspondence to Dr Paul D. Hockings, Imaging Group, GlaxoSmithKline, The Frythe, Welwyn, Herts, AL6 9AR, UK. E-mail paul.d.hockings{at}gsk.com

Background— In vivo methods to evaluate the size and composition of atherosclerotic lesions in animal models of atherosclerosis would assist in the testing of antiatherosclerotic drugs. We have developed an MRI method of detecting atherosclerotic plaque in the major vessels at the base of the heart in low-density lipoprotein (LDL) receptor-knockout (LDLR-/-) mice on a high-fat diet.

Methods and Results— Three-dimensional fast spin-echo magnetic resonance images were acquired at 7 T by use of cardiac and respiratory triggering, with {approx}140-µm isotropic resolution, over 30 minutes. Comparison of normal and fat-suppressed images from female LDLR-/- mice 1 week before and 8 and 12 weeks after the transfer to a high-fat diet allowed visualization and quantification of plaque development in the innominate artery in vivo. Plaque mean cross-sectional area was significantly greater at week 12 in the LDLR-/- mice (0.14±0.086 mm2 [mean±SD]) than in wild-type control mice on a normal diet (0.017±0.031 mm2, P<0.01). In the LDLR-/- mice, but not control mice, increase in plaque burden at week 12 relative to week 1 was also highly significant (P=0.001). Lumen cross section was not significantly different between time points or groups. MRI and histological assessments of plaque size were closely correlated (R=0.8). The lumen of proximal coronary arteries could also be visualized.

Conclusions— This is the first report of in vivo detection of aortic arch atherosclerosis in any animal model. The method could significantly assist rapid evaluation of experimental antiatherosclerotic therapies.


Key Words: magnetic resonance imaging • atherosclerosis • receptors • mice • arteries




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. P. Mayer, C. A. Dyer, R. L. Eastgard, P. B. Hoyer, and C. L. Banka
Atherosclerotic Lesion Development in a Novel Ovary-Intact Mouse Model of Perimenopause
Arterioscler Thromb Vasc Biol, September 1, 2005; 25(9): 1910 - 1916.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. A. McAteer, J. E. Schneider, K. Clarke, S. Neubauer, K. M. Channon, and R. P. Choudhury
Quantification and 3D Reconstruction of Atherosclerotic Plaque Components in Apolipoprotein E Knockout Mice Using Ex Vivo High-Resolution MRI
Arterioscler Thromb Vasc Biol, December 1, 2004; 24(12): 2384 - 2390.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. Trogan, Z. A. Fayad, V. V. Itskovich, J.-G. S. Aguinaldo, V. Mani, J. T. Fallon, I. Chereshnev, and E. A. Fisher
Serial Studies of Mouse Atherosclerosis by In Vivo Magnetic Resonance Imaging Detect Lesion Regression After Correction of Dyslipidemia
Arterioscler Thromb Vasc Biol, September 1, 2004; 24(9): 1714 - 1719.
[Abstract] [Full Text] [PDF]